SlideShare a Scribd company logo
Hepatology lectures for
5th Sem;MBBS
Pratap Sagar Tiwari
MBBS,MD (Medicine),DM (Hepatology)
INTRODUCTION
• Until the beginning of the 21st century, hepatitis showing rapid progression was referred to by various
names, including fulminant hepatitis, fulminant hepatic failure, fulminant liver failure, acute hepatic
failure.
• However, ‘‘acute liver failure’’ came to be used predominantly as the most suitable umbrella term,
because it can be assumed to include all of the other disease entities.
• Thus, the Practice Guideline Committee of AASLD published a paper for the MX of ‘‘acute liver failure’’ in
2005.
• Acute liver failure is defined as ‘‘Severe acute liver injury characterized by the
development of HE and coagulation abnormalities, usually characterized by an INR of
≥1.5, in pts without preexisting cirrhosis, and an illness of <26 weeks duration’’.
CAUSES OF ALF
CLINICAL ASSESSMENT
Cerebral disturbance
Jaundice
HE and/or cerebral oedema
• Early stages: mild and episodic
• Cerebral oedema may occur due to increased intracranial
pressure, causing
❑unequal or abnormally reacting pupils, fixed pupils
❑hypertensive episodes, bradycardia
❑hyperventilation, profuse sweating
❑local or general myoclonus, focal fits or decerebrate posturing
❑Papilloedema occurs rarely and is a late sign.
❑More general symptoms include weakness, nausea and
vomiting.
HEPATIC ENCEPHALOPATHY
CLINICAL ASSESSMENT
Cerebral disturbance
Jaundice
❑ may not be present at the outset (e.g. in paracetamol overdose).
❑ Fetor hepaticus can be present.
❑ The liver is usually of normal size but later becomes smaller.
❑ Hepatomegaly is unusual and, in the presence of a sudden onset
of ascites, suggests venous outflow obstruction as the cause
(Budd–Chiari syndrome).
❑ Splenomegaly is uncommon and never prominent.
❑ Ascites and oedema are late developments.
ADVERSE PROGNOSTIC CRITERIA
ADVERSE PROGNOSTIC CRITERIA
MANAGEMENT
• Patients should be treated in a ICU .
• Conservative treatment aims to maintain life in the hope that hepatic regeneration
will occur, but early transfer to a specialised transplant unit should always be
considered.
• N-acetylcysteine therapy may improve outcome, particularly in patients with
paracetamol poisoning.
• A number of artificial liver support systems have been developed and evaluated for
use as a bridge to either transplantation or recovery. None, however, has entered
routine clinical use.
TOXIC DOSE
• The therapeutic dose of APAP for children <12 years is 15 mg/kg per dose every 4-6 hrs,
(max daily dose 75 mg/kg).
• The therapeutic dose for children 12 years and older and adults is 325-1000 mg per
dose every 4-6 hrs (max daily dose 4 g).
• The minimal toxic dose for an acute ingestion is 150 mg/kg for a child or 10 g for an
adult.
• Virtually all pts who ingest doses in excess of 350 mg/kg develop severe liver toxicity .
Acetaminophen(APAP) Overdosage
12
• Following ingestion, about 2% of APAP is
excreted in the urine unchanged.
• Over 90% is metabolized via conjugation – 2/3rd
via glucuronidation (urine diphosphate (UDP)
glucuronosyltransferases) and 1/3rd through
sulfation (sulfotransferases). The inactive
nontoxic conjugates are largely excreted in the
urine and bile.
APAP: metabolism
13
• The remaining 8% undergoes oxidative conversion via several cytochromes (CYP1A2,
CYP2A6, CYP2E1, CYP3A4) to the highly toxic metabolite N-acetyl-p-benzoquinone
imine (NAPQI) .
• NAPQI is a highly reactive that can act as an
oxidant.
• Normally, it is rapidly metabolized by
conjugation to intracellular glutathione (GSH)
forming a nontoxic APAP-GSH conjugate .
• Subsequent processing leads to its urinary excretion as mercapturic acid and cysteine
conjugates.
• However, under conditions where the supply of NAPQI exceeds the amount of available
glutathione, the former covalently binds hepatocellular proteins, initiating hepatocyte
necrosis.
APAP: metabolism
14
Pts often have few signs/symptoms within 1st 24 hrs, but may develop N/V, and malaise.
Lab studies are usually Normal
24-72 hrs : Pts may develop abdominal pain or liver tenderness and elevations in serum
AST, ALT, PT, and bilirubin.
Acetaminophen(APAP) Overdosage: manifestations
STAGE 1
STAGE 2
15
72–96 hrs, the most severe abnormalities occur –HE, coagulopathy, hyperbilirubinemia (median 4.5
mg/dL), renal dysfunction, and lactic acidosis.
Marked AT elevations (median ∼4,100 IU/L) .
During this stage, death most often occurs from cerebral herniation or from MOF.
Acetaminophen(APAP) Overdosage: manifestations
STAGE 3
4d-2 wks — Pts who survive enter a recovery phase.
Symptoms and lab values may not normalize for several wks.
STAGE 4
16
N-Acetylcysteine for Acetaminophen Overdose
• The use of an antidote may decrease hepatic injury and reverse ALF in
specific circumstances.
• NAC remains the treatment of choice for APAP overdose.
• The administration of NAC replenishes glutathione, thereby detoxifying
NAPQI.
17
Extra note : GI DECONTAMINATION
• Adult patients who present soon after a potentially toxic ingestion of
APAP (single dose ≥7.5 g) are likely to benefit from gastrointestinal
decontamination.
• We suggest treatment with activated charcoal (AC), 1 g/kg (maximum
dose 50 g) by mouth in all patients who present within four hours of a
known or suspected acetaminophen ingestion, unless there are
contraindications to its administration.
• Note: Charcoal should be withheld in patients who are sedated and may
not be able to protect their airway, unless endotracheal intubation is
performed first.
18
Mushroom poisoning
• ALF from ingestion of the mushrooms of the genus Amanita (A. phalloides,
A. verna, and A. virosa) .
• Three medium sized mushrooms (50 g) contain sufficient toxin, α-amanitin
and phalloidin, to cause ALF; the toxins are heat stable and not degraded
by cooking.
• The phallotoxin causes damage to the enterocyte cell membrane.
• The a-amanintin toxin (amatoxin) is dose dependent and responsible for
hepatic injury by disrupting hepatocyte messenger RNA synthesis.
19
Mushroom Poisoning: Course of poisoning
• Following ingestion, a 6–12-hour asymptomatic phase evolves into three
clinical phases.
• The gastrointestinal phase (phase 1; 12–24 hours), consists of diarrhea,
vomiting, and abdominal pain.
• During the hepatotoxic phase (phase 2: 24–48 hours) signs of liver
damage occur and the disease may progress to the third clinical phase
(4– 7 days), during which ALF, hepatorenal syndrome, hemorrhage,
convulsions, coma, and death occur.
• Mortality approaches 10–30% .
20
Mushroom Poisoning
• A combination of penicillin (300,000-1,000,000 U/kg/day, or 250
mg/kg/day iv) and silibinin (20-50 mg/ kg/day iv) has been used as a
specific antidote in those with evidence of liver injury due to Amanita
poisoning.
• These agents are hypothesized to interrupt the enterohepatic circulation of toxins and also to compete
at the hepatocyte membrane for transmembrane transport.
• Because of the rarity of this cause of ALF, the benefits of this regimen remain unproven.
In ALF pts with known or suspected mushroom poisoning, consider administration of
penicillin G and N-acetylcysteine (III). AASLD 2011
Pts with ALF secondary to mushroom poisoning should be listed for transplantation, as
this procedure is often the only lifesaving option (III).AASLD 2011
21
END OF SLDIES

More Related Content

What's hot

Acute Liver Failure
Acute Liver FailureAcute Liver Failure
Acute Liver Failure
Dee Evardone
 
Hepatorenal syndrome
Hepatorenal syndromeHepatorenal syndrome
Hepatorenal syndrome
Praveen Nagula
 
Hypokalemia diagnosis, causes and treatment
Hypokalemia diagnosis, causes and treatmentHypokalemia diagnosis, causes and treatment
Hypokalemia diagnosis, causes and treatment
Garima Aggarwal
 
Ckd mbd
Ckd mbdCkd mbd
Ckd mbd
Harsh shaH
 
Acute liver failure
Acute liver failure Acute liver failure
Acute liver failure
gagan brar
 
Renal tubular acidosis
Renal tubular acidosisRenal tubular acidosis
Renal tubular acidosis
S. Ismat
 
Fulminant hepatic failure
Fulminant hepatic failureFulminant hepatic failure
Fulminant hepatic failure
DrJawad Butt
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failure
Suresh Gorka
 
Renal tubular acidosis
Renal tubular acidosisRenal tubular acidosis
Renal tubular acidosis
subramaniam sethupathy
 
Hepatic encephalopathy
Hepatic encephalopathyHepatic encephalopathy
Hepatic encephalopathy
Chandan N
 
Acute tubular necrosis
Acute tubular necrosisAcute tubular necrosis
Acute tubular necrosis
Mohammad Manzoor
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
Dr. Prem Mohan Jha
 
Approach to Rapidly Progressive Glomerulonephritis RPGN
Approach to Rapidly Progressive Glomerulonephritis RPGNApproach to Rapidly Progressive Glomerulonephritis RPGN
Approach to Rapidly Progressive Glomerulonephritis RPGN
Garima Aggarwal
 
Autoimmune hepatitis rajesh
Autoimmune hepatitis rajeshAutoimmune hepatitis rajesh
Autoimmune hepatitis rajesh
Mohit Aggarwal
 
Att induced hepatitis.pptx new
Att induced hepatitis.pptx newAtt induced hepatitis.pptx new
Att induced hepatitis.pptx new
Bhargav Kiran
 
Acute Kidney Injury
Acute Kidney InjuryAcute Kidney Injury
Acute Kidney Injury
Hayelom Michael Deyo
 
Cardiorenal Syndrome
Cardiorenal SyndromeCardiorenal Syndrome
Cardiorenal Syndrome
Sujay Iyer
 
Antitubercular agents in TB patients with Chronic Liver disease (CLD)
Antitubercular agents in TB patients with Chronic Liver disease (CLD)Antitubercular agents in TB patients with Chronic Liver disease (CLD)
Antitubercular agents in TB patients with Chronic Liver disease (CLD)
Pratap Tiwari
 
Hepatorenal Syndrome
Hepatorenal SyndromeHepatorenal Syndrome
Hepatorenal Syndrome
Muhammad Asim Rana
 
Fulminant hepatic failure
Fulminant hepatic failureFulminant hepatic failure
Fulminant hepatic failure
Ranjithkumar Kondapaka
 

What's hot (20)

Acute Liver Failure
Acute Liver FailureAcute Liver Failure
Acute Liver Failure
 
Hepatorenal syndrome
Hepatorenal syndromeHepatorenal syndrome
Hepatorenal syndrome
 
Hypokalemia diagnosis, causes and treatment
Hypokalemia diagnosis, causes and treatmentHypokalemia diagnosis, causes and treatment
Hypokalemia diagnosis, causes and treatment
 
Ckd mbd
Ckd mbdCkd mbd
Ckd mbd
 
Acute liver failure
Acute liver failure Acute liver failure
Acute liver failure
 
Renal tubular acidosis
Renal tubular acidosisRenal tubular acidosis
Renal tubular acidosis
 
Fulminant hepatic failure
Fulminant hepatic failureFulminant hepatic failure
Fulminant hepatic failure
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failure
 
Renal tubular acidosis
Renal tubular acidosisRenal tubular acidosis
Renal tubular acidosis
 
Hepatic encephalopathy
Hepatic encephalopathyHepatic encephalopathy
Hepatic encephalopathy
 
Acute tubular necrosis
Acute tubular necrosisAcute tubular necrosis
Acute tubular necrosis
 
Acute kidney injury
Acute kidney injuryAcute kidney injury
Acute kidney injury
 
Approach to Rapidly Progressive Glomerulonephritis RPGN
Approach to Rapidly Progressive Glomerulonephritis RPGNApproach to Rapidly Progressive Glomerulonephritis RPGN
Approach to Rapidly Progressive Glomerulonephritis RPGN
 
Autoimmune hepatitis rajesh
Autoimmune hepatitis rajeshAutoimmune hepatitis rajesh
Autoimmune hepatitis rajesh
 
Att induced hepatitis.pptx new
Att induced hepatitis.pptx newAtt induced hepatitis.pptx new
Att induced hepatitis.pptx new
 
Acute Kidney Injury
Acute Kidney InjuryAcute Kidney Injury
Acute Kidney Injury
 
Cardiorenal Syndrome
Cardiorenal SyndromeCardiorenal Syndrome
Cardiorenal Syndrome
 
Antitubercular agents in TB patients with Chronic Liver disease (CLD)
Antitubercular agents in TB patients with Chronic Liver disease (CLD)Antitubercular agents in TB patients with Chronic Liver disease (CLD)
Antitubercular agents in TB patients with Chronic Liver disease (CLD)
 
Hepatorenal Syndrome
Hepatorenal SyndromeHepatorenal Syndrome
Hepatorenal Syndrome
 
Fulminant hepatic failure
Fulminant hepatic failureFulminant hepatic failure
Fulminant hepatic failure
 

Similar to 7. ACUTE LIVER FAILURE

Acute (Fulminant) Liver Failure For Undergraduate.pdf
Acute (Fulminant) Liver Failure For Undergraduate.pdfAcute (Fulminant) Liver Failure For Undergraduate.pdf
Acute (Fulminant) Liver Failure For Undergraduate.pdf
Mohamed Wifi
 
Paracetamol poisoning
Paracetamol poisoningParacetamol poisoning
Paracetamol poisoning
vivek paul benjamin
 
paracetmol-poisoning-160215161539 (1).pdf
paracetmol-poisoning-160215161539 (1).pdfparacetmol-poisoning-160215161539 (1).pdf
paracetmol-poisoning-160215161539 (1).pdf
DrYaqoobBahar
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
Mohammad Omar Ansari
 
Gastroenterology icu management protocol
Gastroenterology icu management protocolGastroenterology icu management protocol
Gastroenterology icu management protocol
Ashish Shrestha
 
Fulminant hepatic failure (fhf)
Fulminant hepatic failure (fhf)Fulminant hepatic failure (fhf)
Fulminant hepatic failure (fhf)
Reyad Al_Faky
 
Neonatal liver failure
Neonatal liver failureNeonatal liver failure
Neonatal liver failure
Manoj Ghoda
 
2 neonatal liver failure
2 neonatal liver failure2 neonatal liver failure
2 neonatal liver failure
Sanjeev Kumar
 
Pancreatitis.2012
Pancreatitis.2012Pancreatitis.2012
Pancreatitis.2012
Dr. Afzal Haq Asif
 
PARACETAMOL POISONING.pptx
PARACETAMOL POISONING.pptxPARACETAMOL POISONING.pptx
PARACETAMOL POISONING.pptx
shanbasat
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failure
AshikMajumder1
 
acuteliverfailure, management-unedited.pptx
acuteliverfailure, management-unedited.pptxacuteliverfailure, management-unedited.pptx
acuteliverfailure, management-unedited.pptx
UmarAliyuSaadu
 
acute fatty liver with pregnancy
acute fatty liver with pregnancyacute fatty liver with pregnancy
acute fatty liver with pregnancy
Mohammed Abdalla
 
Tylenol Toxicity
Tylenol ToxicityTylenol Toxicity
Tylenol Toxicity
Rodolfo Rodrigo Acosta
 
Acute Paracetamol overdose
Acute Paracetamol overdose Acute Paracetamol overdose
Acute Paracetamol overdose
akshatusa
 
PARACETAMOL POISONING.pptx
PARACETAMOL POISONING.pptxPARACETAMOL POISONING.pptx
PARACETAMOL POISONING.pptx
NESHANTHI1
 
Pediatric Pancreatitis - Rivin
Pediatric Pancreatitis - RivinPediatric Pancreatitis - Rivin
Pediatric Pancreatitis - Rivin
Rivindu Wickramanayake
 
Jaundice in pregnancy (3) (2).pptx
Jaundice in pregnancy (3) (2).pptxJaundice in pregnancy (3) (2).pptx
Jaundice in pregnancy (3) (2).pptx
Dr.Asha Choudhary
 
ANESTHESIA FOR PTS WITH LIVER DISEASE.pptx
ANESTHESIA FOR PTS WITH LIVER DISEASE.pptxANESTHESIA FOR PTS WITH LIVER DISEASE.pptx
ANESTHESIA FOR PTS WITH LIVER DISEASE.pptx
rijjorajoo
 
1. hepatic coma converted
1. hepatic coma converted1. hepatic coma converted
1. hepatic coma converted
Daisy Thomas
 

Similar to 7. ACUTE LIVER FAILURE (20)

Acute (Fulminant) Liver Failure For Undergraduate.pdf
Acute (Fulminant) Liver Failure For Undergraduate.pdfAcute (Fulminant) Liver Failure For Undergraduate.pdf
Acute (Fulminant) Liver Failure For Undergraduate.pdf
 
Paracetamol poisoning
Paracetamol poisoningParacetamol poisoning
Paracetamol poisoning
 
paracetmol-poisoning-160215161539 (1).pdf
paracetmol-poisoning-160215161539 (1).pdfparacetmol-poisoning-160215161539 (1).pdf
paracetmol-poisoning-160215161539 (1).pdf
 
Acute pancreatitis
Acute pancreatitisAcute pancreatitis
Acute pancreatitis
 
Gastroenterology icu management protocol
Gastroenterology icu management protocolGastroenterology icu management protocol
Gastroenterology icu management protocol
 
Fulminant hepatic failure (fhf)
Fulminant hepatic failure (fhf)Fulminant hepatic failure (fhf)
Fulminant hepatic failure (fhf)
 
Neonatal liver failure
Neonatal liver failureNeonatal liver failure
Neonatal liver failure
 
2 neonatal liver failure
2 neonatal liver failure2 neonatal liver failure
2 neonatal liver failure
 
Pancreatitis.2012
Pancreatitis.2012Pancreatitis.2012
Pancreatitis.2012
 
PARACETAMOL POISONING.pptx
PARACETAMOL POISONING.pptxPARACETAMOL POISONING.pptx
PARACETAMOL POISONING.pptx
 
Acute liver failure
Acute liver failureAcute liver failure
Acute liver failure
 
acuteliverfailure, management-unedited.pptx
acuteliverfailure, management-unedited.pptxacuteliverfailure, management-unedited.pptx
acuteliverfailure, management-unedited.pptx
 
acute fatty liver with pregnancy
acute fatty liver with pregnancyacute fatty liver with pregnancy
acute fatty liver with pregnancy
 
Tylenol Toxicity
Tylenol ToxicityTylenol Toxicity
Tylenol Toxicity
 
Acute Paracetamol overdose
Acute Paracetamol overdose Acute Paracetamol overdose
Acute Paracetamol overdose
 
PARACETAMOL POISONING.pptx
PARACETAMOL POISONING.pptxPARACETAMOL POISONING.pptx
PARACETAMOL POISONING.pptx
 
Pediatric Pancreatitis - Rivin
Pediatric Pancreatitis - RivinPediatric Pancreatitis - Rivin
Pediatric Pancreatitis - Rivin
 
Jaundice in pregnancy (3) (2).pptx
Jaundice in pregnancy (3) (2).pptxJaundice in pregnancy (3) (2).pptx
Jaundice in pregnancy (3) (2).pptx
 
ANESTHESIA FOR PTS WITH LIVER DISEASE.pptx
ANESTHESIA FOR PTS WITH LIVER DISEASE.pptxANESTHESIA FOR PTS WITH LIVER DISEASE.pptx
ANESTHESIA FOR PTS WITH LIVER DISEASE.pptx
 
1. hepatic coma converted
1. hepatic coma converted1. hepatic coma converted
1. hepatic coma converted
 

More from Pratap Tiwari

Primary Biliary cholangitis, lecture class for MBBS
Primary Biliary cholangitis, lecture class for MBBSPrimary Biliary cholangitis, lecture class for MBBS
Primary Biliary cholangitis, lecture class for MBBS
Pratap Tiwari
 
Wilson's Disease
Wilson's DiseaseWilson's Disease
Wilson's Disease
Pratap Tiwari
 
HCV MANAGEMENT IN PATIENT WITH KIDNEY DISEASE..reuploaded
HCV MANAGEMENT IN PATIENT WITH KIDNEY DISEASE..reuploadedHCV MANAGEMENT IN PATIENT WITH KIDNEY DISEASE..reuploaded
HCV MANAGEMENT IN PATIENT WITH KIDNEY DISEASE..reuploaded
Pratap Tiwari
 
HEMOCHROMATOSIS
HEMOCHROMATOSISHEMOCHROMATOSIS
HEMOCHROMATOSIS
Pratap Tiwari
 
Liver transplantation; notes of DM/DNB/Specialists
Liver transplantation; notes of DM/DNB/SpecialistsLiver transplantation; notes of DM/DNB/Specialists
Liver transplantation; notes of DM/DNB/Specialists
Pratap Tiwari
 
9.LIVER ABSCESS
9.LIVER ABSCESS9.LIVER ABSCESS
9.LIVER ABSCESS
Pratap Tiwari
 
6. HEPATIC ENCEPHALOPATHY
6. HEPATIC ENCEPHALOPATHY6. HEPATIC ENCEPHALOPATHY
6. HEPATIC ENCEPHALOPATHY
Pratap Tiwari
 
5. Alcohol related liver diease
5. Alcohol related liver diease5. Alcohol related liver diease
5. Alcohol related liver diease
Pratap Tiwari
 
4. ASCITES part 2.pdf
4. ASCITES part 2.pdf4. ASCITES part 2.pdf
4. ASCITES part 2.pdf
Pratap Tiwari
 
3. ASCITES part 1.pdf
3. ASCITES part 1.pdf3. ASCITES part 1.pdf
3. ASCITES part 1.pdf
Pratap Tiwari
 
2. PORTAL HYPERTENSION
2. PORTAL HYPERTENSION 2. PORTAL HYPERTENSION
2. PORTAL HYPERTENSION
Pratap Tiwari
 
Chronic liver disease
Chronic liver disease Chronic liver disease
Chronic liver disease
Pratap Tiwari
 
Alcohol related liver disease focussing on “Alcoholic Hepatitis”
Alcohol related liver disease focussing on “Alcoholic Hepatitis”Alcohol related liver disease focussing on “Alcoholic Hepatitis”
Alcohol related liver disease focussing on “Alcoholic Hepatitis”
Pratap Tiwari
 
Acute on chronic liver failure
Acute on chronic liver failureAcute on chronic liver failure
Acute on chronic liver failure
Pratap Tiwari
 
HCV in CKD
HCV in CKDHCV in CKD
HCV in CKD
Pratap Tiwari
 
TIPS in Ascites
TIPS in AscitesTIPS in Ascites
TIPS in Ascites
Pratap Tiwari
 
Acute Variceal Hemorrhage
Acute Variceal HemorrhageAcute Variceal Hemorrhage
Acute Variceal Hemorrhage
Pratap Tiwari
 
Role of tips in liver disease
Role of tips in liver diseaseRole of tips in liver disease
Role of tips in liver disease
Pratap Tiwari
 
HCV in unique population
HCV in unique population HCV in unique population
HCV in unique population
Pratap Tiwari
 
Extra hepatic portal vein obstruction
Extra hepatic portal vein obstructionExtra hepatic portal vein obstruction
Extra hepatic portal vein obstruction
Pratap Tiwari
 

More from Pratap Tiwari (20)

Primary Biliary cholangitis, lecture class for MBBS
Primary Biliary cholangitis, lecture class for MBBSPrimary Biliary cholangitis, lecture class for MBBS
Primary Biliary cholangitis, lecture class for MBBS
 
Wilson's Disease
Wilson's DiseaseWilson's Disease
Wilson's Disease
 
HCV MANAGEMENT IN PATIENT WITH KIDNEY DISEASE..reuploaded
HCV MANAGEMENT IN PATIENT WITH KIDNEY DISEASE..reuploadedHCV MANAGEMENT IN PATIENT WITH KIDNEY DISEASE..reuploaded
HCV MANAGEMENT IN PATIENT WITH KIDNEY DISEASE..reuploaded
 
HEMOCHROMATOSIS
HEMOCHROMATOSISHEMOCHROMATOSIS
HEMOCHROMATOSIS
 
Liver transplantation; notes of DM/DNB/Specialists
Liver transplantation; notes of DM/DNB/SpecialistsLiver transplantation; notes of DM/DNB/Specialists
Liver transplantation; notes of DM/DNB/Specialists
 
9.LIVER ABSCESS
9.LIVER ABSCESS9.LIVER ABSCESS
9.LIVER ABSCESS
 
6. HEPATIC ENCEPHALOPATHY
6. HEPATIC ENCEPHALOPATHY6. HEPATIC ENCEPHALOPATHY
6. HEPATIC ENCEPHALOPATHY
 
5. Alcohol related liver diease
5. Alcohol related liver diease5. Alcohol related liver diease
5. Alcohol related liver diease
 
4. ASCITES part 2.pdf
4. ASCITES part 2.pdf4. ASCITES part 2.pdf
4. ASCITES part 2.pdf
 
3. ASCITES part 1.pdf
3. ASCITES part 1.pdf3. ASCITES part 1.pdf
3. ASCITES part 1.pdf
 
2. PORTAL HYPERTENSION
2. PORTAL HYPERTENSION 2. PORTAL HYPERTENSION
2. PORTAL HYPERTENSION
 
Chronic liver disease
Chronic liver disease Chronic liver disease
Chronic liver disease
 
Alcohol related liver disease focussing on “Alcoholic Hepatitis”
Alcohol related liver disease focussing on “Alcoholic Hepatitis”Alcohol related liver disease focussing on “Alcoholic Hepatitis”
Alcohol related liver disease focussing on “Alcoholic Hepatitis”
 
Acute on chronic liver failure
Acute on chronic liver failureAcute on chronic liver failure
Acute on chronic liver failure
 
HCV in CKD
HCV in CKDHCV in CKD
HCV in CKD
 
TIPS in Ascites
TIPS in AscitesTIPS in Ascites
TIPS in Ascites
 
Acute Variceal Hemorrhage
Acute Variceal HemorrhageAcute Variceal Hemorrhage
Acute Variceal Hemorrhage
 
Role of tips in liver disease
Role of tips in liver diseaseRole of tips in liver disease
Role of tips in liver disease
 
HCV in unique population
HCV in unique population HCV in unique population
HCV in unique population
 
Extra hepatic portal vein obstruction
Extra hepatic portal vein obstructionExtra hepatic portal vein obstruction
Extra hepatic portal vein obstruction
 

Recently uploaded

TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
Donc Test
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
SwisschemDerma
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Tina Purnat
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
chandankumarsmartiso
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
NephroTube - Dr.Gawad
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Dr. Madduru Muni Haritha
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
drhasanrajab
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
Swastik Ayurveda
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Oleg Kshivets
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 

Recently uploaded (20)

TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...
 
Top Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in IndiaTop Effective Soaps for Fungal Skin Infections in India
Top Effective Soaps for Fungal Skin Infections in India
 
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptxshare - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in DehradunDehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
Dehradun #ℂall #gIRLS Oyo Hotel 8107221448 #ℂall #gIRL in Dehradun
 
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.GawadHemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
Hemodialysis: Chapter 4, Dialysate Circuit - Dr.Gawad
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradeshBasavarajeeyam - Ayurvedic heritage book of Andhra pradesh
Basavarajeeyam - Ayurvedic heritage book of Andhra pradesh
 
Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.ABDOMINAL TRAUMA in pediatrics part one.
ABDOMINAL TRAUMA in pediatrics part one.
 
Best Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and IndigestionBest Ayurvedic medicine for Gas and Indigestion
Best Ayurvedic medicine for Gas and Indigestion
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
Local Advanced Lung Cancer: Artificial Intelligence, Synergetics, Complex Sys...
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 

7. ACUTE LIVER FAILURE

  • 1. Hepatology lectures for 5th Sem;MBBS Pratap Sagar Tiwari MBBS,MD (Medicine),DM (Hepatology)
  • 2. INTRODUCTION • Until the beginning of the 21st century, hepatitis showing rapid progression was referred to by various names, including fulminant hepatitis, fulminant hepatic failure, fulminant liver failure, acute hepatic failure. • However, ‘‘acute liver failure’’ came to be used predominantly as the most suitable umbrella term, because it can be assumed to include all of the other disease entities. • Thus, the Practice Guideline Committee of AASLD published a paper for the MX of ‘‘acute liver failure’’ in 2005. • Acute liver failure is defined as ‘‘Severe acute liver injury characterized by the development of HE and coagulation abnormalities, usually characterized by an INR of ≥1.5, in pts without preexisting cirrhosis, and an illness of <26 weeks duration’’.
  • 4. CLINICAL ASSESSMENT Cerebral disturbance Jaundice HE and/or cerebral oedema • Early stages: mild and episodic • Cerebral oedema may occur due to increased intracranial pressure, causing ❑unequal or abnormally reacting pupils, fixed pupils ❑hypertensive episodes, bradycardia ❑hyperventilation, profuse sweating ❑local or general myoclonus, focal fits or decerebrate posturing ❑Papilloedema occurs rarely and is a late sign. ❑More general symptoms include weakness, nausea and vomiting.
  • 6. CLINICAL ASSESSMENT Cerebral disturbance Jaundice ❑ may not be present at the outset (e.g. in paracetamol overdose). ❑ Fetor hepaticus can be present. ❑ The liver is usually of normal size but later becomes smaller. ❑ Hepatomegaly is unusual and, in the presence of a sudden onset of ascites, suggests venous outflow obstruction as the cause (Budd–Chiari syndrome). ❑ Splenomegaly is uncommon and never prominent. ❑ Ascites and oedema are late developments.
  • 7.
  • 10. MANAGEMENT • Patients should be treated in a ICU . • Conservative treatment aims to maintain life in the hope that hepatic regeneration will occur, but early transfer to a specialised transplant unit should always be considered. • N-acetylcysteine therapy may improve outcome, particularly in patients with paracetamol poisoning. • A number of artificial liver support systems have been developed and evaluated for use as a bridge to either transplantation or recovery. None, however, has entered routine clinical use.
  • 11.
  • 12. TOXIC DOSE • The therapeutic dose of APAP for children <12 years is 15 mg/kg per dose every 4-6 hrs, (max daily dose 75 mg/kg). • The therapeutic dose for children 12 years and older and adults is 325-1000 mg per dose every 4-6 hrs (max daily dose 4 g). • The minimal toxic dose for an acute ingestion is 150 mg/kg for a child or 10 g for an adult. • Virtually all pts who ingest doses in excess of 350 mg/kg develop severe liver toxicity . Acetaminophen(APAP) Overdosage 12
  • 13. • Following ingestion, about 2% of APAP is excreted in the urine unchanged. • Over 90% is metabolized via conjugation – 2/3rd via glucuronidation (urine diphosphate (UDP) glucuronosyltransferases) and 1/3rd through sulfation (sulfotransferases). The inactive nontoxic conjugates are largely excreted in the urine and bile. APAP: metabolism 13 • The remaining 8% undergoes oxidative conversion via several cytochromes (CYP1A2, CYP2A6, CYP2E1, CYP3A4) to the highly toxic metabolite N-acetyl-p-benzoquinone imine (NAPQI) .
  • 14. • NAPQI is a highly reactive that can act as an oxidant. • Normally, it is rapidly metabolized by conjugation to intracellular glutathione (GSH) forming a nontoxic APAP-GSH conjugate . • Subsequent processing leads to its urinary excretion as mercapturic acid and cysteine conjugates. • However, under conditions where the supply of NAPQI exceeds the amount of available glutathione, the former covalently binds hepatocellular proteins, initiating hepatocyte necrosis. APAP: metabolism 14
  • 15. Pts often have few signs/symptoms within 1st 24 hrs, but may develop N/V, and malaise. Lab studies are usually Normal 24-72 hrs : Pts may develop abdominal pain or liver tenderness and elevations in serum AST, ALT, PT, and bilirubin. Acetaminophen(APAP) Overdosage: manifestations STAGE 1 STAGE 2 15
  • 16. 72–96 hrs, the most severe abnormalities occur –HE, coagulopathy, hyperbilirubinemia (median 4.5 mg/dL), renal dysfunction, and lactic acidosis. Marked AT elevations (median ∼4,100 IU/L) . During this stage, death most often occurs from cerebral herniation or from MOF. Acetaminophen(APAP) Overdosage: manifestations STAGE 3 4d-2 wks — Pts who survive enter a recovery phase. Symptoms and lab values may not normalize for several wks. STAGE 4 16
  • 17. N-Acetylcysteine for Acetaminophen Overdose • The use of an antidote may decrease hepatic injury and reverse ALF in specific circumstances. • NAC remains the treatment of choice for APAP overdose. • The administration of NAC replenishes glutathione, thereby detoxifying NAPQI. 17
  • 18. Extra note : GI DECONTAMINATION • Adult patients who present soon after a potentially toxic ingestion of APAP (single dose ≥7.5 g) are likely to benefit from gastrointestinal decontamination. • We suggest treatment with activated charcoal (AC), 1 g/kg (maximum dose 50 g) by mouth in all patients who present within four hours of a known or suspected acetaminophen ingestion, unless there are contraindications to its administration. • Note: Charcoal should be withheld in patients who are sedated and may not be able to protect their airway, unless endotracheal intubation is performed first. 18
  • 19. Mushroom poisoning • ALF from ingestion of the mushrooms of the genus Amanita (A. phalloides, A. verna, and A. virosa) . • Three medium sized mushrooms (50 g) contain sufficient toxin, α-amanitin and phalloidin, to cause ALF; the toxins are heat stable and not degraded by cooking. • The phallotoxin causes damage to the enterocyte cell membrane. • The a-amanintin toxin (amatoxin) is dose dependent and responsible for hepatic injury by disrupting hepatocyte messenger RNA synthesis. 19
  • 20. Mushroom Poisoning: Course of poisoning • Following ingestion, a 6–12-hour asymptomatic phase evolves into three clinical phases. • The gastrointestinal phase (phase 1; 12–24 hours), consists of diarrhea, vomiting, and abdominal pain. • During the hepatotoxic phase (phase 2: 24–48 hours) signs of liver damage occur and the disease may progress to the third clinical phase (4– 7 days), during which ALF, hepatorenal syndrome, hemorrhage, convulsions, coma, and death occur. • Mortality approaches 10–30% . 20
  • 21. Mushroom Poisoning • A combination of penicillin (300,000-1,000,000 U/kg/day, or 250 mg/kg/day iv) and silibinin (20-50 mg/ kg/day iv) has been used as a specific antidote in those with evidence of liver injury due to Amanita poisoning. • These agents are hypothesized to interrupt the enterohepatic circulation of toxins and also to compete at the hepatocyte membrane for transmembrane transport. • Because of the rarity of this cause of ALF, the benefits of this regimen remain unproven. In ALF pts with known or suspected mushroom poisoning, consider administration of penicillin G and N-acetylcysteine (III). AASLD 2011 Pts with ALF secondary to mushroom poisoning should be listed for transplantation, as this procedure is often the only lifesaving option (III).AASLD 2011 21